Metraipolis › archive › dc_527e62f05ffd

Outcomes of Platelet-Rich Plasma Versus Dextrose 10% Prolotherapy in the Treatment of Osgood-Schlatter Disease: A Retrospective Study — Europe PMC PMID:41111815

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41111815
DOI
10.7759/cureus.92414
License (as archived)
solo-consultazione
Archived
2026-11-09T22:35:26.735Z
SHA-256 of the archived text
a862465cf2069ade44d721de841b2dc8bd3ed56de7b001672913b41cf422f0d6
Stable URL of this page
https://metraipolis.com/documento/dc_527e62f05ffd

How to cite

Outcomes of Platelet-Rich Plasma Versus Dextrose 10% Prolotherapy in the Treatment of Osgood-Schlatter Disease: A Retrospective Study — Europe PMC PMID:41111815 — Europe PMC (en), https://europepmc.org/article/MED/41111815 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_527e62f05ffd (Metraipolis archive dc_527e62f05ffd, sha256 a862465cf2069ade44d721de841b2dc8bd3ed56de7b001672913b41cf422f0d6)
BibTeX
@misc{dc527e62f05ffd,
  title = {Outcomes of Platelet-Rich Plasma Versus Dextrose 10% Prolotherapy in the Treatment of Osgood-Schlatter Disease: A Retrospective Study — Europe PMC PMID:41111815},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41111815},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_527e62f05ffd; sha256 a862465cf2069ade44d721de841b2dc8bd3ed56de7b001672913b41cf422f0d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41111815. Agents can read the archived copy with the MCP tool read_document.